Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Maraganore DM, et al. Among authors: papapetropoulos s. JAMA. 2006 Aug 9;296(6):661-70. doi: 10.1001/jama.296.6.661. JAMA. 2006. PMID: 16896109
Expression of alpha-synuclein mRNA in Parkinson's disease.
Papapetropoulos S, Adi N, Mash DC, Shehadeh L, Bishopric N, Shehadeh L. Papapetropoulos S, et al. Mov Disord. 2007 May 15;22(7):1057-9; author reply 1057. doi: 10.1002/mds.21466. Mov Disord. 2007. PMID: 17373725 No abstract available.
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Wider C, et al. Among authors: papapetropoulos s. Mov Disord. 2009 Feb 15;24(3):455-9. doi: 10.1002/mds.22442. Mov Disord. 2009. PMID: 19133659 Free PMC article.
Phenotypic associations of tau and ApoE in Parkinson's disease.
Papapetropoulos S, Farrer MJ, Stone JT, Milkovic NM, Ross OA, Calvo L, McQuorquodale D, Mash DC. Papapetropoulos S, et al. Neurosci Lett. 2007 Mar 6;414(2):141-4. doi: 10.1016/j.neulet.2006.12.008. Epub 2007 Jan 3. Neurosci Lett. 2007. PMID: 17204369
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Wider C, Ross OA, Nishioka K, Heckman MG, Vilariño-Güell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW. Wider C, et al. Among authors: papapetropoulos s. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):424-9. doi: 10.1136/jnnp-2011-301413. Epub 2012 Jan 30. J Neurol Neurosurg Psychiatry. 2012. PMID: 22291217 Free PMC article.
Glucosidase-beta variations and Lewy body disorders.
Farrer MJ, Williams LN, Algom AA, Kachergus J, Hulihan MM, Ross OA, Rajput A, Papapetropoulos S, Mash DC, Dickson DW. Farrer MJ, et al. Among authors: papapetropoulos s. Parkinsonism Relat Disord. 2009 Jul;15(6):414-6. doi: 10.1016/j.parkreldis.2008.08.004. Epub 2008 Oct 1. Parkinsonism Relat Disord. 2009. PMID: 18829375 Free PMC article.
171 results